ATS Stat

HomeATS Stat ▶ Stat June 24, 2020
Stat June 24, 2020

Congratulations, ATS 2019 Journal Award Winners!

In recognition of their exemplary work across the ATS journals, the ATS is delighted to present the 2019 Journal Reviewer Awards. Awards are based on the number of original research reviews, reviews of new submissions, as they require more reviewer time, as well as the quality of the reviews—length and breadth.  View the winners, and learn more!

The ATS is also pleased to present the 2019 winners of the AJRCMB Junior Investigator Awards. This prestigious award highlights one or more manuscripts for which the first or senior author qualifies as a Junior Investigator in each issue of the published Journal. View the winners!

 

Help Us Help Members!

Even while working on the frontlines of the pandemic, ATS members have made time to create a variety resources, available at ATS COVID-19 Response, and in the weekly COVID-19 Update email.

But with COVID-19 numbers still rising in the United States, and in anticipation of another surge in COVID-19 this fall, this fight is far from over. As such, we’re seeking feedback to help us identify the resources that would be most beneficial to you.

By taking a few minutes to respond to this survey, you’re helping us maximize Society resources. Thank you for the work you’re doing!

Industry Innovations Webinar Series

Tomorrow! Best Practices in Remote Patient Monitoring for the Respiratory Specialist

Hear from a panel of international respiratory specialists on how they are rapidly adapting their models of care in light of COVID-19. This webinar provides key learnings from major centers with established respiratory remote monitoring programs, discussion on how to maximize the value of your respiratory patient remote monitoring data, and an overview of solutions from leading respiratory remote monitoring provider patientMpower.

When: 4 p.m. ET, June 25, 2020
.Register now.
Supported by patientMpower.

Treatable Traits Approach Towards COPD Management for Busy Pulmonologists

With the GOLD 2020 strategy document, the focus on utilization of the treatable traits approach of symptoms and exacerbations for COPD management continues to gain prominence. This program will provide a concise update for busy pulmonary practitioners using a case-based approach with a focus on the implementation of the concepts of this “treatable traits” approach in COPD management.

This webinar is only for HCP’s located in the U.S.

When: 6:30 p.m. ET, July 7, 2020
Register now!  
Webinar is sponsored by GlaxoSmithKline. 

 

Earn CME/CE Credit in Upcoming "Immunology Basics" Webinars

Join us for a two-part webinar series* presented by the American Thoracic Society in partnership with AKH.

Part one of this series, "Immunology Basics for the Non-Immunologist Clinician: Clinical Implications," will address advances in basic clinical immunology, and its application to the phenotypes and endotypes of severe asthma. Leading experts will discuss the role of biomarkers in severe asthma and their utilization in assessing severity and determining appropriate therapy.

When: 1 p.m. ET, July 16, 2020  
Register now.


Part two of this series, "Individualizing Treatment for Severe Asthma," will apply the foundational information developed in part one, and will discuss the use of phenotypes, endotypes, and biomarkers in the clinical management of severe asthma.
When:  1 p.m. ET, July 30, 2020
Register now.

All CME/CE accreditation and credit designation statements are available on the webinar registration page.

This educational activity is supported by an educational grant from GlaxoSmithKline.

 

 

Upcoming Webinars!

Join the RCMB Assembly Innovation and Entrepreneurial Working Group for a webinar, “Drug Development and Clinical Trials in the COVID-19 Era. You can email your questions in advance to  vukmirom@mcmaster.ca

When: 12 p.m. ET, June 26, 2020
Register now



Join the virtual Science and Innovation Center for “Beyond Alum and Capsular Polysaccharides.”

When: 5 p.m. ET, June 30, 2020  
Register now.